Economic Evaluation of Heart Failure Management in Colombian Clinics
NCT ID: NCT01084564
Last Updated: 2010-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2008-01-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decision Making for the Management the Symptoms in Adults of Heart Failure
NCT03549169
Batch n ° 2 of the Public Market Evaluation "Medico-economic Demonstrator IsereADOM"
NCT03457623
Monitoring Community Trends in Heart Failure
NCT00035724
A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure
NCT07217106
A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure
NCT05036967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
moderate to severe uncontrolled asthma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rodolfo Dennis, M.D.
Role: STUDY_DIRECTOR
Pontificia Universidad Javeriana
MARÍA XIMENA ROJAS, M.D.
Role: PRINCIPAL_INVESTIGATOR
Pontificia Universidad Javeriana
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CCO-ATA-2007/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.